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Abstract. Toluene-2,4-diisocyanate (TDI) induced occupational asthma mechanisms are not completely 
known. The aim of the study was to evaluate the nitro-oxidative stress associated to experimental mice 
TDI induced asthma. It was used a model of mice experimental exposure to TDI for 10 days. The study 
groups (n = 12) were: a negative control group with skin sensitization and intranasal challenge, performed 
with saline; group with sensitization and challenge with the solvent; group with 
sensitization and challenge with TDI; groups with TDI and aminoguanidine (AG) (50 mg/kg/d i.p.) or 
NG-nitro-L-arginine methyl ester (NAME), (5 mg/kg/d i.p.) or arginine (ARG) (100 mg/kg/d i.p.) or 
trolox (20 mg / kg / day ip). On the 11th day blood was collected by cardiac puncture, and nitro-oxidative 
stress was assessed by total oxidative status (TOS), total antioxidative capacity (TAC), oxidative stress 
index (OSI) and serum nitrates and nitrites (NOx). TDI increased TOS, OSI and NOx and 
reduced TAC. The solvent did not influence any parameter. AG, NAME and Trolox reduced NOx, TOS 
and OSI. Experimental exposure of mice to TDI caused systemic nitro-oxidative stress, and NOx 
reduction and Trolox lowered the systemic nitro-oxidative stress. 
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INTRODUCTION 
 
Disocyanates are low molecular weight chemicals widely used in industry for the 
production of polyurethane foams, varnish, paint, and isulation material, and are one of the 
leading causes of occupational asthma worldwide. Asthma pathogenesis is complex and and 
involves a combination of immune, genetic, environmental and socio-economic factors. 
Experimental animal models of diisocyanate occupational asthma have demonstrated an 
immunological basis for the disease (Vanoirbeek et al., 2009). 
Oxidative and nitrative stress plays an important role in disease pathogenesis and in 
tissue damage in response to toxicant exposures. These and other inflammatory mediators are 
released by phagocytic leukocytes and infiltrating macrophages in the lung (Bessac et al., 2009; 
Roberts et al., 2009). Nitric oxide (NO) is produced in macrophages via an inducible form of the 
enzyme, NO synthase (iNOS or NOS2). Inflammatory mediators such as bacterially derived 
lipopolysaccharide (LPS), and cytokines like tumor necrosis factor alpha (TNF-a), lead to 
activation of signaling pathways, subsequent activation NF-kB, upregulation of iNOS, and 
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excessive production of reactive oxygen and nitrogen species (Roberts et al., 2009). Reactive 
oxygen species (ROS) released directly or indirectly by mononuclear phagocytes, can contribute 
to airway inflammation through the induction of cytokines, chemokines and adhesion molecules 
via the NF-_B pathway and mitogen-activated protein kinase cascades in macrophages and 
epithelial cells (Maes et al., 2010). The associated oxidative and nitrative stress promotes diverse 
pathologic reactions like chronic inflammation, atherosclerosis and cancer (Roberts et al., 2009). 
In humans, TDI-induced asthma shares many characters of atopic asthma manifested by 
a latency period, persistent airway hyperreactivity to chemical-specific and nonspecific challenge, 
and airway inflammation, involving the presence of activated T cells, eosinophils, neutrophils, 
and mast cells (Matheson et al., 2002). Murine model for occupational asthma generates both 
inflammatory and immune mediators similar to those occurring in TDI-induced asthma in 
humans (Matheson et al., 2001). 
Animal models have shown that sensitization can occur through subchronic inhalation of 
vapor-phase diisocyanate at levels as low as 20 ppb. It was also shown that almost all chemical 
sensitizers can lead to primary sensitization when they are applied to the skin. Mice can be 
sensitized by dermal or respiratory exposure, suggesting that either the exposure route may be 
important in studying TDI-induced asthma mechanisms (Matheson et al., 2004).  
The purpose of our present study was to evaluate the level of systemic nitro-oxidative 
stress in a mice model of isocyanate-induced asthma, and to test the efficacy of the NO synthesis 
reduction with NOS inhibitors and antioxidant treatment with Trolox. 
 
MATERIALS AND METHODS 
 
Chemicals  
Toluene-2,4-diisocyanate (98%; Fluka, CAS 584-84-9) was obtained from Aldrich 
Chemical Co. (Taufkirchen, Germany). The vehicle (AOO) used to dissolve the TDI consisted of 
a mixture of 2 volumes of acetone (Borealis AG, Viena, Austria) and 3 volumes of olive oil 
(extra virgin, Pietro Coricelli S.p.a., Spoleto, Italy). Concentrations of TDI are given as 
percentages (v/v). Sulfanilamide (SULF), N-(1-Naphthyl) ethylenediamine dihydrochloride 
(NEDD), Vanadium (III) chloride (VCl3), methanol, diethylether, xylenol orange [o-
cresosulfonphthalein-3,3-bis(sodium methyliminodiacetate)], ortho dianisidine dihydrochloride 
(3-3′-dimethoxybenzidine), ferrous ammonium sulfate, hydrogen peroxide (H2O2), sulfuric acid, 
hydrochloride acid, glycerolwere purchased from Merck (Darmstadt, Germany) and Sigma-
Aldrich (Taufkirchen, Germany). All chemicals were of analysis grade.  
Groups of animals and treatment protocol  
Mice were housed at the Animal Facility of Iuliu Hatieganu University of Medicine and 
Pharmacy (Cluj Napoca, Romania) in standard environmental conditions (12-h light/dark cycle 
and _23°C), and received water and pelleted food ad libitum. All animal procedures were 
approved by the Iuliu Hatieganu University of Medicine and Pharmacy (Cluj-Napoca, Romania) 
Ethical Committee for Animal Experiments. Animals were identically matched for age and sex 
(approximately 20 g, 5-6 weeks old male mice). As previously described, on days 1, 2, 3 and 7, 
the animals received a dermal application (20 μl) with 0.3% TDI, or vehicle (AOO, 2:3) on the 
dorsum of both ears. On day 10, they received, under light diethyl ether anesthesia, an intranasal 
instillation (10 μl/nostril) of 0.1% TDI (challenge), or vehicle (AOO, 1:4) (Tarkowski et al., 
2007).  Mice were deeply anesthetized with pentobarbital (90 mg/kg i.p.) and sacrificed 24 hours 
after the challenge (Figure 1). In all experiments, treatment with TDI is indicated as 1, and 
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treatment with vehicle is indicated as 0. Thus, there were seven study groups: negative 
CONTROL group, mice that received dermal sensitization and an intranasal challenge with saline 
solution; group 1/1 (TDI), mice that received dermal sensitization with TDI and an intranasal 
challenge with TDI; group 0/0 mice that received the AOO vehicle on all occasions; group 
1/1+AG, mice that received TDI on all occasions and a selective nitric oxide synthase 2 (NOS2) 
inhibitor, aminoguanidine (AG) (50 mg/kg/d i.p.) treatment (Devaux et al., 2001); group 
1/1+NAME, mice that received TDI on all occasions and NG-nitro-L-arginine methyl ester 
(NAME), a nonselective nitric oxide synthase (NOS) inhibitor, (5 mg/kg/d i.p.) treatment (Byun 
et al.,2009); group 1/1+ARG, mice that received TDI on all occasions and NO synthesis substrate, 
arginine (ARG) (100 mg/kg/d i.p.) (Hess, 2010); group 1/1+Trolox, mice that received TDI on all 
occasions and Trolox treatment (20 mg/kg/d i.p)(McClung et al., 2007). Each group consisted of 12 
animals. Treatments were administated from day one to day 10. Twenty-four hours after the airway 
challenge, mice were killed by a pentobarbital overdose and blood was collected. 
 
  
 
 
Fig. 1. Schematic diagram of the experimental TDI-induced asthma protocol. 
Mice were sensitized twice by two periods of dermal administration of 3% TDI once a day for 3 consecutive days 
with a 3-day interval, plus one day. Three days after the second period of sensitization, mice were challenged via the 
nose with 0,1% TDI. The AG, NAME or Trolox treatment were administered once/day, from day one to day 10. In 
day 11 blood samples were collected. TDI = Toluene-2,4-diisocyanate; AG = aminoguanidine; NAME = NG-nitro-
L-arginine methyl ester; ARG = arginine. 
 
Serum total nitrite and nitrate determination  
 
The Griess reaction was used as an indirect assay to determine the total nitrite and nitrate 
(NOx) as a measure of the degree of NO production. The serum sample were deproteinized by 
methanol/diethylether (3/1, v/v) (sample: methanol/diethylether, 1:9, v/v) (Ghasemi et al., 2007).  
Deproteinized samples were then used for NOx determination. In brief, to 100 μL of 
supernatant 100 μL VCl3 (8mg/ml) was added for reduction of nitrate to nitrite and this was 
followed by addition of the Griess reagents, 50 μL SULF (2%) and 50 μL NEED (0.1%).  
After 30 min incubation at 37 ºC, absorbance was read at 540 nm. Serum NOx level was 
expressed in nitrite μmol/L (Miranda et al., 2001). 
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Serum total oxidant status determination  
Total oxidant status (TOS) of serum was measured using a colorimetric measurement 
method (Erel, 2005). In this method oxidants present in the sample oxidize the ferrous ion-o-
dianisidine complex to ferric ion. The oxidation reaction is enhanced by glycerol molecules, which 
are abundantly present in the reaction medium. The ferric ion makes a colored complex with xylenol 
orange in an acidic medium. The color intensity, which can be measured spectrophotometrically, is 
related to the total amount of oxidant molecules present in the sample. The assay is calibrated with 
hydrogen peroxide (H2O2) and the results are expressed in μmol H2O2 Equiv./L. 
Serum total antioxidant response determination 
The total antioxidant status was measured in serum using a colorimetric method for the 
total antioxidant response (TAR). In this method the hydroxyl radical is produced by the Fenton 
reaction, and reacts with the colorless substrate o-dianisidine to produce the dianisyl radical, 
which is bright yellowish-brown in color. Upon addition of a serum sample, the oxidative 
reactions initiated by the hydroxyl radicals present in the reaction medium are suppressed by the 
antioxidant components of the serum, preventing the color change and thereby providing an 
effective measure of the total antioxidant capacity of the serum. The assay is calibrated with 
Trolox and results are expressed as mmol Trolox Equiv./L (Erel, 2004) 
Calculation of oxidative stress index  
The percent ratio of the total oxidative status to the total antioxidant response gave the 
oxidative stress index (OSI), an indicator of the degree of oxidative stress (Harma et al., 2003). 
To perform the calculation, the result unit of TAR, mmol Trolox equivalent/L, was changed to 
μmol Trolox equivalent/L and OSI was calculated with the formula:  OSI (Arbitrary Unit) = TOS 
(μmol H2O2 Equiv. /L) / TAC (mmol Trolox Equiv./L). 
Statistical analyses. Preliminary studies of the potential effects of Trolox treatment 
were analysed using independent t tests. Comparisons between groups for each dependent 
variable measured were made by one-way analysis of variance (ANOVA). Results are reported as 
means and standard error (SE). A p-value of 0.05 or less was regarded as significant. 
 
RESULTS 
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Fig. 2. Total nitrites and nitrates. AOO = acetone olive oil; TDI = Toluene-2,4-diisocyanate; AG = 
aminoguanidine; NAME = NG-nitro-L-arginine methyl ester; ARG = arginine. 
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Compared to the CONTROL group, total NOx increased significantly at TDI group 
(p<0.001), and the vehicle had no important influence (p>0.05). Compared to the TDI group, AG, 
NAME, and TROLOX caused a significant reduction of the NOx (p<0.001). ARG did not 
influenced NOX compared to TDI (p>0.05) (fig.2). 
TDI caused a significant increase of TOS (p<0.001), and AOO had no important effect 
(p>0.05). compared to TDI, AG, NAME, and TROLOX caused a significant reduction of the 
TOS (p<0.001). ARG did not influenced TOS compared to TDI (p>0.05) (fig.3). 
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Figure 3: Total oxidative status (TOS). AOO = acetone olive oil; TDI = Toluene-2,4-diisocyanate; AG 
= aminoguanidine; NAME = NG-nitro-L-arginine methyl ester; ARG = arginine. 
 
 
Compared to the CONTROL group, TAC did not increased significantly at TDI group 
(p>0.05), and the vehicle had no important influence (p>0.05). Compared to the TDI group, AG, 
NAME, ARG and TROLOX caused a small increase of TAC (p>0.05) (fig.4). 
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Figure 4: Total antioxidant capacity (TAC). AOO = acetone olive oil; TDI = Toluene-2,4-diisocyanate; 
AG = aminoguanidine; NAME = NG-nitro-L-arginine methyl ester; ARG = arginine. 
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At TDI group OSI increased significantly (p<0.01), and the vehicle had no important 
influence (p>0.05). Compared to the TDI group, AG, NAME, and TROLOX caused a significant 
reduction of OSI (p<0.001). ARG did not influenced OSI compared to TDI (p>0.05) (fig.5). 
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Figure 5: Oxidative stress index (OSI). AOO = acetone olive oil; TDI = Toluene-2,4-diisocyanate; AG 
= aminoguanidine; NAME = NG-nitro-L-arginine methyl ester; ARG = arginine. 
 
 
DISCUSSIONS 
 
Despite the frequent isocyanate exposures in occupational and environmental medicine, 
the molecular and cellular mechanism of injury and irritation elicited by TDI exposures is not 
completely known. In our present study, we have demonstrated that TDI cause nitro-oxidative 
stress, and substances that reduce NO and ROS production may reduce it.  
Dependent on exposure levels and duration, TDIs are equally strong irritants and cause 
asthma-related symptoms on repeated exposures. Current medical treatment of exposures 
includes the removal of the toxicants by dilution, washing, and chemical neutralization, treatment 
of pain with antiinflammatory drugs and general and local anesthetics, and stabilization of the 
airways with bronchodilators. Although these procedures are helpful, the additional use of 
pharmacological agents to block the specific mechanisms of isocyanates would allow a more 
efficient treatment (Bessac et al., 2008). 
Mouse models are a valuable tool to study the potential effects of TDI in asthma 
pathogenesis. They allow histological, biochemical and functional tests that may reveal the 
pathophysiology of the process. One of the key areas of recent interest is the role that nitro-
oxidative stress plays in mediating the response to toxicants via cytotoxic pathway.  
Tissue damage induced by toxicants involves activation of cell survival and apoptosis 
pathways. Two broad categories of apoptosis networks, referred to as the intrinsic and extrinsic 
pathways have been identified (Aslan et al., 2008). The extrinsic pathway is activated by 
inflammatory mediators receptors such as the tumor necrosis factor-a (TNF-a) receptor.  
The intrinsic pathway is triggered by cellular stress and signals to the mitochondria 
which then engage caspase 9 through cytochrome c release. Both pathways converge on caspase 
8 leading to cellular death (Roberts et al., 2009). 
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The present study found an important increase of the TOS and NOx.  The sources are the 
perivascular and in the interstitial tissue were there was a rich inflammatory infiltrate with 
mononuclear, neutrophils and eosinophils (Perseca, et al., 2012; Matheson et al., 2005). Reactive 
nitrogen species (RNS) and reactive oxygen species (ROS) can modulate survival signaling 
molecules (Aslan et al., 2008), but are also capable to cause DNA damage, leading to apoptosis 
pathways activation. In the same time NO down regulates nuclear factor jB (NF-jB) which 
protects from apoptosis (Roberts et al., 2009). 
Administration of selective and nonselective NOS inhibitors, AG and NAME suggested 
that excessive NO release from the activated inflammatory cells is an important part of the 
pathogenetic mechanism in experimental TDI-induced asthma. The antioxidant trolox caused a 
reduction of the nitro-oxidative stress too. Trolox effect was explained by the histological 
evidences of inflammatory infiltrate reduction (Perseca et al., 2012).  
When produced in excess NO and ROS, they react and form other RNS. This 
mechanism may explain why ARG administration did not increased NOx, but increased oxidative 
stress. The limited efficacies of immune-directed therapies asthmatic airway inflammation 
suggest the involvement of additional mechanisms. Evidence showed a bi-directional feedback 
between immunogenic and neurogenic mechanisms (Bessac et al., 2010).  
Neuronal activation causes pain and irritation, neurogenic inflammation, mucus secretion, 
and reflex responses, such as cough, sneezing, and bronchoconstriction. Members of the transient 
receptor potential (TRP) superfamily of ion channels play a key role in the response of sensory 
neurons to inflammatory mediators. The 2 major pro-inflammatory TRP ion channels TRPV1, the 
capsaicin receptor, and TRPA1, activated by mustard oil. Reactive oxygen species and lipid 
peroxidation products are endogenous TRPA1 agonists (Bessac et al., 2009). The high level of TOS 
and OSI at TDI group suggested the possibility that a neurogenic mechanism may be associated. 
It was found that isocyanates chemically react with NH2- and OH-groups of many 
proteins, as for example the already mentioned tubulin, albumin, creatin-18, and glutathione 
(GSH) (Vanoirbeek et al., 2009). Experimental data suggest that airway GSH may help prevent 
the development of allergic sensitization and asthma (Wisnewski et al., 2005). 
The reduction of functional GSH caused by binding of isocyanate could lead to 
increasing oxidative exposure, resulting finally in apoptosis of bronchial epithelial cells 
(Wisnewski et al., 2010; Fisseler et al., 2011). Our results showed that TAC did not change 
significantly at TDI animals. These suggested that GSH decrease was not important, and that 
oxidative stress was induced by the higher production of oxidants. 
 
 
CONCLUSIONS 
 
In conclusion, the present study proved that in the mouse model of TDI-induced asthma, 
nitro-oxidative stress is an important pathogenetic mechanism. Since the additional use of NOS 
inhibitors and the antioxidant Trolox reduced the nitro-oxidative stress, the pharmacological 
substances that target nitro-oxidative stress may become efficient treatment tools. 
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